Heron Therapeutics (HRTX) Insider Trading
Officer, director, and 10%+ owner transactions reported to the SEC on Form 4, with buy/sell totals and cluster activity for Heron Therapeutics.
Bought (12 mo)
$0
Sold (12 mo)
$0
Insiders Buying (12 mo)
0
Insiders Selling (12 mo)
0
Form 4 Filings (All Time)
191
Most Recent Purchase
August 12, 2025
Adam Morgan
Director
$3,699,999
Most Recent Sale
May 4, 2022
Kimberly Manhard
EVP
$7,154
Buys (90d)
0
Sells (90d)
0
Recent Insider Transactions
| Filed | Insider | Role | Type | Value | % Change |
|---|---|---|---|---|---|
| 2026-10-21 | Collard Craig A | CEO | Exercise | — | +1.2% |
| 2026-10-21 | Duarte Ira | CFO | Exercise | — | +1.0% |
| 2026-10-21 | Forbes William P | Officer | Exercise | — | +1.1% |
| 2026-08-10 | Hensley Mark Earl | Officer | Exercise | — | +14.2% |
| 2026-08-03 | Collard Craig A | CEO | Exercise | — | +11.0% |
| 2026-08-03 | Duarte Ira | CFO | Exercise | — | +6.8% |
| 2026-08-03 | Forbes William P | Officer | Exercise | — | +7.4% |
| 2026-08-03 | Hensley Mark Earl | Officer | Exercise | — | +8.6% |
Sign up free to view more insider trades.